Neonatal Intensive Care Respiratory Devices Market Report 2026

Neonatal Intensive Care Respiratory Devices Market Overview

• Neonatal Intensive Care Respiratory Devices market size has reached to $2.61 billion in 2025 • Expected to grow to $4.35 billion in 2030 at a compound annual growth rate (CAGR) of 10.7% • Growth Driver: Surge In Prevalence Of Neonatal Respiratory Complications Is Fueling The Market Growth Due To Rising Need For Advanced Respiratory Support In Newborns • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Neonatal Intensive Care Respiratory Devices Market?

Neonatal intensive care respiratory devices are specialized medical devices designed to support breathing in newborns who experience respiratory distress or underdeveloped lung function. These devices help deliver oxygen, regulate airflow, and provide assisted ventilation to stabilize neonatal breathing. They are essential tools in maintaining proper respiratory function for fragile newborns requiring intensive medical support. The main product types of neonatal intensive care respiratory devices are ventilators, continuous positive airway pressure devices, oxygen delivery devices, inhalers, humidifiers, and others. Ventilators are critical respiratory support systems designed to assist or replace spontaneous breathing in neonates with compromised lung function. These devices are used across invasive ventilation, non-invasive ventilation, and combined or hybrid systems, designed for gestational age groups including extremely preterm, very preterm, moderate to late preterm, and full-term infants with respiratory conditions, among end users such as hospitals, neonatal clinics, ambulatory surgical centers, and others.

What Is The Neonatal Intensive Care Respiratory Devices Market Growth Forecast?

The neonatal intensive care respiratory devices market size is expected to see rapid growth in the next few years. It will grow to $4.35 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing adoption of non-invasive respiratory technologies, rising demand for advanced NICU respiratory equipment, growing investments in neonatal critical care, increasing need for improved neonatal survival outcomes, rising awareness of preterm birth complications, growing healthcare spending on infant care, increasing use of automated respiratory monitoring, rising technological enhancements in neonatal devices, growing focus on early intervention respiratory support, increasing preference for safe and effective ventilation systems. Major trends in the forecast period include advancement in non-invasive neonatal ventilation, advancement in compact and portable respiratory devices, advancement in automated respiratory monitoring, innovation in neonatal oxygen delivery systems, innovation in ai-assisted ventilation tools, innovation in high-flow nasal cannula devices, integration of smart monitoring sensors, integration with real-time nicu data platforms, integration of tele-neonatology capabilities, advancement in hybrid ventilation technologies.

Global Neonatal Intensive Care Respiratory Devices Market Segmentation

1) By Product Type: Ventilators, Continuous Positive Airway Pressure (CPAP) Devices, Oxygen Delivery Devices, Inhalers, Humidifiers, Others Product Types 2) By Modality: Invasive Ventilation, Non-Invasive Ventilation, Combined Or Hybrid Systems 3) By Gestational Age: Extremely Preterm (<28 Weeks), Very Preterm (28–32 Weeks), Moderate To Late Preterm (32–37 Weeks), Full Term With Respiratory Conditions 4) By End User: Hospitals, Neonatal Clinics, Ambulatory Surgical Centers, Others End User Subsegments: 1) By Ventilators: Invasive Mechanical Ventilators, Non-Invasive Ventilators, Portable Ventilators, Intensive Care Unit (ICU) Ventilators, Emergency Or Transport Ventilators 2) By Continuous Positive Airway Pressure (CPAP) Devices: Fixed-Pressure CPAP Devices, Auto-Adjusting (APAP) CPAP Devices, Bi-Level Positive Airway Pressure (BiPAP) Devices, Portable Or Home CPAP Devices, Hospital Or Clinical CPAP Devices 3) By Oxygen Delivery Devices: Oxygen Concentrators, Oxygen Cylinders Or Tanks, Oxygen Masks, Nasal Cannulas, Portable Oxygen Systems 4) By Inhalers: Metered Dose Inhalers (MDI), Dry Powder Inhalers (DPI), Soft Mist Inhalers (SMI), Nebulizer Inhalers, Combination Drug Inhalers 5) By Humidifiers: Ultrasonic Humidifiers, Evaporative Humidifiers, Steam Vaporizers, Impeller Humidifiers, Hospital-Grade Respiratory Humidifiers 6) By Others Product Types: Nebulizers (Standalone), Suction Devices, Respiratory Monitors, Airway Clearance Devices, Tracheostomy Care Devices

What Are The Drivers Of The Neonatal Intensive Care Respiratory Devices Market?

The increasing prevalence of neonatal respiratory complications is expected to propel the growth of the neonatal intensive care respiratory devices market going forward. Neonatal respiratory complications are breathing disorders in newborns, such as respiratory distress syndrome and transient tachypnea, that impair lung function shortly after birth and are a major cause of neonatal morbidity and mortality. The rise in neonatal respiratory complications is due to higher rates of prematurity and greater medical complexity at birth, leading more infants to require intensive respiratory support. Neonatal intensive care respiratory devices support neonatal respiratory complications by enabling assisted ventilation, precise oxygen delivery, and continuous respiratory monitoring, helping clinicians stabilize infants and improve survival outcomes. For instance, in October 2024, according to the Royal College of Paediatrics and Child Health, a UK-based professional medical body, The proportion of babies experiencing bronchopulmonary dysplasia or death varied across regions, ranging from 32.6% in the East of England to 46.8% in the Northern Operational Delivery Network, with individual neonatal units reporting rates between 0% and 61.7% for units with at least 10 eligible babies. Therefore, the increasing prevalence of neonatal respiratory complications is driving the growth of the neonatal intensive care respiratory devices industry. The rising investment in neonatal care equipment is expected to propel the growth of the neonatal intensive care respiratory devices market going forward. Investment in neonatal care equipment refers to the allocation of financial resources by governments and public health systems toward acquiring and upgrading medical devices and infrastructure specifically for newborn health services, including neonatal intensive care devices. The rising investment in neonatal care equipment is due to the growing need for precise thermal regulation, as preterm and low-birth-weight infants struggle to maintain stable body temperature on their own. Rising investment in neonatal care equipment enhances neonatal intensive care respiratory devices by enabling the development and adoption of advanced technologies that provide precise, reliable respiratory support for premature and critically ill infants. This improves survival rates, reduces complications, and supports better overall neonatal outcomes. For instance, in November 2025, according to the OECD, a Paris-based international economic organization, average annual capital expenditure on health across member countries rose from 0.60% of GDP in 2024 to 0.62% of GDP in 2025, with a notable share allocated to medical equipment, indicating a year-on-year increase in public sector investment in health infrastructure and devices, including neonatal care equipment. Therefore, rising investment in neonatal care equipment is driving the growth of the neonatal intensive care respiratory devices industry.

Key Players In The Global Neonatal Intensive Care Respiratory Devices Market

Major companies operating in the neonatal intensive care respiratory devices market are Medtronic plc, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Becton, Dickinson and Company (BD), ResMed Inc., Drägerwerk AG & Co. KGaA, Getinge AB, Smiths Group plc, Teleflex Incorporated, Masimo Corporation, Fisher & Paykel Healthcare Limited, Comen Medical, Hamilton Medical AG, GaleMed Corporation, Heyer Medical AG, Inspiration Healthcare Group plc, Mercury Medical, Trudell Medical International Co., Atom Medical International Co. Ltd., Airon Corporation, Lowenstein Medical Technology GmbH

What Are Latest Mergers And Acquisitions In The Neonatal Intensive Care Respiratory Devices Market?

In January 2024, Inspiration Healthcare Group plc, a UK-based provider of neonatal and critical care medical technology, acquired Airon Corporation for approximately $2.5 million. With this acquisition, Inspiration Healthcare expanded its global footprint and strengthened its neonatal respiratory device portfolio by adding Airon’s pneumatic ventilators and CPAP systems, enhancing its commercial platform for neonatal respiratory support, particularly in the US and North American markets. Airon Corporation is a US-based manufacturer of specialist pneumatic oxygen-powered life support ventilators and continuous positive airway pressure (CPAP) systems used in neonatal and intensive care settings.

Regional Insights

North America was the largest region in the neonatal intensive care respiratory devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Neonatal Intensive Care Respiratory Devices Market?

The neonatal intensive care respiratory devices market consists of sales of ventilators, continuous positive airway pressure (CPAP) devices, oxygen delivery systems, respiratory monitors, and humidification systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Neonatal Intensive Care Respiratory Devices Market Report 2026?

The neonatal intensive care respiratory devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the neonatal intensive care respiratory devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.